Tafamidis meglumine - Pfizer
At a glance
- Drug Originator FoldRx Pharmaceuticals
- Drug Class Benzoxazoles; Carboxylic acids; Cardiovascular therapies; Chlorobenzenes; Neuroprotectants; Small molecules
- Mechanism of Action Amyloid inhibitors
- USA Patent Applicants FOLDRX PHARMS
- USA Patents 8
- NDAs 2
- International Patents 66
- Patent Applications 109
Table of Contents

Disclaimer